Federated Hermes’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.21K | Hold |
46
| – | – | ﹤0.01% | 1988 |
|
|
2026
Q1 | $1.69K | Hold |
46
| – | – | ﹤0.01% | 1978 |
|
|
2025
Q4 | $2.34K | Sell |
46
-34
| -43% | -$1.74K | ﹤0.01% | 1958 |
|
|
2025
Q3 | $4.44K | Sell |
80
-34,206
| -100% | -$2M | ﹤0.01% | 1954 |
|
|
2025
Q2 | $2.37M | Sell |
34,286
-85,040
| -71% | -$5.78M | ﹤0.01% | 891 |
|
|
2025
Q1 | $8.29M | Sell |
119,326
-46,122
| -28% | -$3.81M | 0.02% | 600 |
|
|
2024
Q4 | $14.2M | Sell |
165,448
-32,765
| -17% | -$3.54M | 0.03% | 474 |
|
|
2024
Q3 | $23.6M | Sell |
198,213
-11,498
| -5% | -$1.53M | 0.05% | 388 |
|
|
2024
Q2 | $29.9M | Sell |
209,711
-12,742
| -6% | -$1.69M | 0.07% | 308 |
|
|
2024
Q1 | $28.6M | Sell |
222,453
-16,375
| -7% | -$1.95M | 0.07% | 339 |
|
|
2023
Q4 | $24.7M | Sell |
238,828
-5,988
| -2% | -$592K | 0.06% | 342 |
|
|
2023
Q3 | $22.3M | Buy |
244,816
+428
| +0.2% | +$37.7K | 0.06% | 344 |
|
|
2023
Q2 | $19.8M | Buy |
244,388
+26,076
| +12% | +$2.13M | 0.05% | 391 |
|
|
2023
Q1 | $17.4M | Sell |
218,312
-38,564
| -15% | -$2.73M | 0.04% | 431 |
|
|
2022
Q4 | $17.4M | Buy |
256,876
+89,264
| +53% | +$5.23M | 0.05% | 416 |
|
|
2022
Q3 | $8.35M | Buy |
167,612
+1,060
| +0.6% | +$56.8K | 0.02% | 570 |
|
|
2022
Q2 | $9.28M | Buy |
166,552
+166,470
| +203,012% | +$9.24M | 0.03% | 563 |
|
|
2022
Q1 | $5K | Hold |
82
| – | – | ﹤0.01% | 1959 |
|
|
2021
Q4 | $5K | Hold |
82
| – | – | ﹤0.01% | 1992 |
|
|
2021
Q3 | $4K | Hold |
82
| – | – | ﹤0.01% | 2056 |
|
|
2021
Q2 | $3K | Buy |
+82
| New | +$3.18K | ﹤0.01% | 2079 |
|
|
2017
Q3 | – | Sell |
-41,600
| Closed | -$892K | – | 2181 |
|
|
2017
Q2 | $892K | Sell |
41,600
-145,600
| -78% | -$2.94M | ﹤0.01% | 1246 |
|
|
2017
Q1 | $3.21M | Sell |
187,200
-74,600
| -28% | -$1.3M | 0.01% | 725 |
|
|
2016
Q4 | $4.69M | Hold |
261,800
| – | – | 0.01% | 580 |
|
|
2016
Q3 | $5.44M | Buy |
261,800
+16,000
| +7% | +$397K | 0.02% | 547 |
|
|
2016
Q2 | $6.61M | Hold |
245,800
| – | – | 0.02% | 489 |
|
|
2016
Q1 | $6.66M | Sell |
245,800
-112,000
| -31% | -$3M | 0.02% | 489 |
|
|
2015
Q4 | $10.4M | Sell |
357,800
-12,000
| -3% | -$332K | 0.03% | 431 |
|
|
2015
Q3 | $10M | Sell |
369,800
-101,600
| -22% | -$2.88M | 0.03% | 436 |
|
|
2015
Q2 | $12.9M | Sell |
471,400
-15,134
| -3% | -$425K | 0.04% | 411 |
|
|
2015
Q1 | $13M | Buy |
486,534
+40,734
| +9% | +$938K | 0.04% | 398 |
|
|
2014
Q4 | $9.43M | Sell |
445,800
-37,200
| -8% | -$831K | 0.03% | 469 |
|
|
2014
Q3 | $11.5M | Sell |
483,000
-11,000
| -2% | -$253K | 0.04% | 405 |
|
|
2014
Q2 | $11.4M | Buy |
494,000
+7,600
| +2% | +$168K | 0.04% | 424 |
|
|
2014
Q1 | $11.1M | Sell |
486,400
-236,600
| -33% | -$5.04M | 0.04% | 437 |
|
|
2013
Q4 | $13.4M | Sell |
723,000
-195,000
| -21% | -$3.4M | 0.05% | 371 |
|
|
2013
Q3 | $15.5M | Sell |
918,000
-312,000
| -25% | -$5.25M | 0.06% | 279 |
|
|
2013
Q2 | $19.1M | Buy |
+1,230,000
| New | +$20.5M | 0.08% | 212 |
|
Other funds holding NVO
F
Federated Hermes's NVO Position: Q2 2026 in Review
Federated Hermes held its Novo Nordisk (NVO) position steady in Q2 2026 at 46 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.
Federated Hermes first reported a position in NVO in Q2 2013 and has held it in 38 quarters since. The position peaked at $29.9M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Federated Hermes held 46 shares of Novo Nordisk worth $2.21K as of Q2 2026.
- Federated Hermes left its Novo Nordisk share count unchanged in Q2 2026.
- Novo Nordisk made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1988 holding.
- Federated Hermes first reported a position in Novo Nordisk in Q2 2013 and has held it in 38 quarters since.
- Federated Hermes's Novo Nordisk position peaked at $29.9M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.